MedPath

ALCEDIAG

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects

Not Applicable
Recruiting
Conditions
Bipolar Disorder
Major Depressive Disorder
First Posted Date
2024-07-18
Last Posted Date
2025-02-18
Lead Sponsor
Alcediag
Target Recruit Count
450
Registration Number
NCT06507787
Locations
🇫🇷

CH Erstein, Erstein, France

🇫🇷

AP-HP Corentin Celton, Issy-les-Moulineaux, France

🇫🇷

Etablissement Public de Santé Mentale (EPSM) 74, La Roche-sur-Foron, France

and more 4 locations

Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers

Completed
Conditions
Major Depressive Disorder
Bipolar Disorder
First Posted Date
2022-11-03
Last Posted Date
2024-12-17
Lead Sponsor
Alcediag
Target Recruit Count
418
Registration Number
NCT05603819
Locations
🇩🇰

The Capital Region of Denmark, Copenhagen, Denmark

🇫🇷

GHU Paris Psychiatrie & Neurosciences, Paris, France

🇪🇸

Parc Sanitari Sant Joan de Déu, Sant Boi De Llobregat, Barcelona, Spain

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.